The Cornell Veterinary Biobank (CVB) is proud to announce that Dr. Lara Mouttham’s paper, “A Biobank's Journey: Implementation of a Quality Management System and Accreditation to ISO 20387” was
Watch or read the November 27th, 2022, 60 Minutes story by Anderson Cooper featuring comparative oncology and interviews with Drs. Elaine Ostrander and Nicola Mason.
NEW YORK (Sept. 9, 2022)—Weill Cornell Medicine was awarded a $61.9 million grant from the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) to continue
An article published on March 21, 2021, in the Denver Gazette by Joey Bunch describes the impactful, translational cancer research in dogs taking place at Colorado State University's Flint Animal
CARY, NC (December 21, 2020) – The V Foundation for Cancer Research, a top-rated cancer research charity, has awarded three Comparative Oncology Research Consortium (CORC) grants of $500,000 each. The
Tufts Cummings School of Veterinary Medicine is part of a multi-institution study to assess if a new field treatment would benefit military working dogs—and maybe someday pets in hemorrhagic shock By Genevieve Rajewski
After years of planning and months of implementation, the Cornell Veterinary Biobank has achieved international accreditation under a new global standard, making it the first biobank of any type to
Since 2003, NCI has been using information from studies of canine cancer to help guide studies of human cancer and vice versa—a field known as comparative oncology.
Researchers at the University of Georgia and Emory University have developed a new therapy that may hasten the recovery of patients who have suffered a stroke. The stem-cell based therapy was tested
Veterinarians at the Cummings School of Veterinary Medicine at Tufts University are currently evaluating a new drug to treat dogs with degenerative myelopathy, a disease similar to amyotrophic lateral
A team of researchers at the Schools of Medicine and Veterinary Medicine at the University of California-Davis has described a new way to increase the anti-cancer activity of natural killer cells – a
In a first-of-its-kind study, University of Missouri scientists have helped advance a patient-specific, precision medicine treatment for bone cancer (osteosarcoma, OSA) in dogs. By creating a vaccine